Monthly Archives: September 2014

Five Imperatives for Pharma’s Digital Health Strategy

Posted on September 26, 2014 by David Lee Scher, MD

Few would argue that today digital technology represents a critical part of marketing in any business sector.  Though all healthcare stakeholders are usually late to the technology table, market and customer pressure are rapidly accelerating this adoption. It needs to … Continue reading →

Posted in clinical trials, digital health, FDA, healthcare economics, Healthcare IT, medical apps, mHealth, patient advocacy, patient engagement, pharma, technology, telehealth, wireless health | Tagged , , , , , , , , , | 5 Comments

Five Ways Digital Health Technology Can Impact Risk Management

Posted on September 9, 2014 by David Lee Scher, MD

There has been a significant amount of well-deserved publicity regarding HIPAA violations arising from security breaches of electronic health records (EHRs). Even a well-intentioned company which developed a certification process (which included privacy and security) for mobile medical apps encountered … Continue reading →

Posted in digital health, FDA, Healthcare IT, IT security, malpractice law, mHealth, mobile health, patient engagement, remote patient monitoring, risk management, smartphone apps, telehealth | Tagged , , , , , , , , | 1 Comment